Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.43 |
| ▸ | KYNU | Q16719 | 2/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | GCLC | P48506 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.41 |
| ▸ | GSR | P00390 | 2/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22720617 | 1.00 | PTGS1 (0.44) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL180559 | 0.97 | PTGS1 (0.46) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL21518548 | 0.97 | PTGS1 (0.46) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL44030 | 0.97 | PTGS1 (0.46) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL44031 | 0.97 | PTGS1 (0.46) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL30600100 | 0.97 | PTGS1 (0.46) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL1395227 | 0.97 | PTGS1 (0.46) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| Ethylene SCHEMBL8819545 | 0.95 | PTGS1 (0.41) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL6570277 | 0.95 | PTGS1 (0.44) | PTGS1SLC7A11PMP22KYNUNOS2 | |
| SCHEMBL5046067 | 0.95 | PTGS1 (0.44) | PTGS1SLC7A11PMP22KYNUNOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7375246-B2 | Sulfhydral containing compounds and methods of using the same | REGENESIS BIOREMEDIATION PRODUCTS INC. (US) | 2008-05-20 | — | — | US | disclosed |
| US-20050148712-A1 | Polyol esters of sulfhydryl carboxylic acids; treating water and water-containing soils contaminated with metal | FARONE WILLIAM A (US) | 2005-07-07 | — | — | US | disclosed |
| US-6846947-B2 | Sulfhydral containing compounds and methods of using same | REGENESIS BIOREMEDIATION PRODUCTS, INC. (US) | 2005-01-25 | — | — | US | disclosed |
| US-20040157316-A1 | Sulfhydral containing compounds and methods of using same | REGENESIS | 2004-08-12 | — | — | US | disclosed |
| US-20040158095-A1 | Sulfhydral containing compounds and methods of using same | REGENESIS, INC. | 2004-08-12 | — | — | US | disclosed |
| US-6733651-B1 | Method for producing a cyanide-free solution of a gold compound that is suitable for galvanic gold baths | W. C. HERAEUS GMBH & CO. KG (DE) | 2004-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040158095-A1 | Sulfhydral containing compounds and methods of using same | TST, QSOX1, CTH | PTGS1 285/4885SLC7A11 90/4885PMP22 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.